| Title | Venue | Year | Impact | Source |
| 3201 | AZD-1222: Massive splenoportal axis thrombosis: case report | N/A | 2022 | | CORD-19 |
| 3202 | Methylprednisolone: Lack of efficacy following off-label use: case report | N/A | 2022 | | CORD-19 |
| 3203 | Tozinameran: Aseptic meningitis: case report | N/A | 2022 | | CORD-19 |
| 3204 | Multiple drugs: Off-label use and lack of efficacy: 8 case reports | N/A | 2022 | | CORD-19 |
| 3205 | AZD-1222/tozinameran: Immune thrombocytopenia: 10 case reports | N/A | 2022 | | CORD-19 |
| 3206 | AZD-1222: Central retinal artery occlusion: case report | N/A | 2022 | | CORD-19 |
| 3207 | Elasomeran/sodium-chloride: Rhabdomyolysis, fasciitis and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3208 | Azd-1222: Subacromial-subdeltoid bursitis and immune-mediated inflammatory reaction following medication error: case report | N/A | 2022 | | CORD-19 |
| 3209 | Dexamethasone/favipiravir: Rebound effect leading to pulmonary embolism and deep vein thrombosis following off-label use: case report | N/A | 2022 | | CORD-19 |
| 3210 | Hydrochlorothiazide: Hypokalaemia: 2 case reports | N/A | 2022 | | CORD-19 |
| 3211 | AZD-1222/sars-cov-2-vaccine-inactivated-sinovac-biotech: Anaphylaxis and pityriasis rosea: case report | N/A | 2022 | | CORD-19 |
| 3212 | Non-serious case reports | N/A | 2022 | | CORD-19 |
| 3213 | Elasomeran/tozinameran: Exacerbation of idiopathic thrombocytopenic purpura and acute-onset immune thrombocytopenia: 3 case reports | N/A | 2022 | | CORD-19 |
| 3214 | Ad26.cov2-s: Bell's palsy: case report | N/A | 2022 | | CORD-19 |
| 3215 | Covid-19-vaccine-gamaleya-national-research-center-of-epidemiology-and-microbiology: Neuromyelitis optica spectrum disorder: case report | N/A | 2022 | | CORD-19 |
| 3216 | Multiple drugs: Lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3217 | Tramadol: Various toxicities following accidental tramadol poisoning: case report | N/A | 2022 | | CORD-19 |
| 3218 | Azd-1222: Paroxysmal supraventricular tachycardia and fever: case report | N/A | 2022 | | CORD-19 |
| 3219 | Azd-1222: Herpes simplex encephalitis: case report | N/A | 2022 | | CORD-19 |
| 3220 | Sodium-chloride/tozinameran: Inflammatory myositis and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3221 | Tozinameran: Myeloperoxidase anti-neutrophil cytoplasmic antibody positive subacute optic perineuritis: case report | N/A | 2022 | | CORD-19 |
| 3222 | Tozinameran: Bell's palsy: case report | N/A | 2022 | | CORD-19 |
| 3223 | Elasomeran: Non-infectious endocarditis and myocarditis: case report | N/A | 2022 | | CORD-19 |
| 3224 | Elasomeran/tozinameran: Flare of myasthenia gravis: 3 case reports | N/A | 2022 | | CORD-19 |
| 3225 | AZD-1222: Acute Haemorrhagic Encephalomyelitis: 3 case reports | N/A | 2022 | | CORD-19 |
| 3226 | Methylprednisolone/prednisolone: Lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3227 | Favipiravir: Acute psychosis following off-label use: case report | N/A | 2022 | | CORD-19 |
| 3228 | AZD-1222/tozinameran: Haemophagocytic-lymphohistiocytosis: 2 case reports | N/A | 2022 | | CORD-19 |
| 3229 | Multiple drugs: DRESS-syndrome and rebound effect: case report | N/A | 2022 | | CORD-19 |
| 3230 | Tozinameran: Myocarditis and pain at the injection site: 5 case reports | N/A | 2022 | | CORD-19 |
| 3231 | AZD-1222: Tinnitus and acute cochleopathy: case report | N/A | 2022 | | CORD-19 |
| 3232 | Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders | N/A | 2022 | | CORD-19 |
| 3233 | SARS-COV-2-vaccine-inactivated-Sinovac-Biotech: Atrial fibrillation: case report | N/A | 2022 | | CORD-19 |
| 3234 | Sars-cov-2-vaccine-inactivated-sinovac-biotech: Takotsubo syndrome: case report | N/A | 2022 | | CORD-19 |
| 3235 | Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report | N/A | 2022 | | CORD-19 |
| 3236 | Amoxicillin/clavulanic-acid/tozinameran: Vulvar Aphthous ulcer and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3237 | Infliximab: Autoimmune hepatitis: case report | N/A | 2022 | | CORD-19 |
| 3238 | Azd-1222: Cutaneous small-vessel vasculitis: case report | N/A | 2022 | | CORD-19 |
| 3239 | Tozinameran: Myocarditis: case report | N/A | 2022 | | CORD-19 |
| 3240 | The Roles of Legacy Versus Social Media Information Seeking in American and Chinese Consumers' Hoarding During COVID-19 Through two studies conducted with cross-cultural samples (the United States and China), this research examines the psychological mechanism of consumer hoarding during COVID-19. Findings from Study 1 suggest that consumer hoarding is differently affected by legacy and social media information seeking, perceived scarcity, and scarcity attributions in the United States versus China. For China, while social media information seeking has a negative downstream relationship to hoarding, legacy media information seeking has a positive relationship with hoarding. In the United States, only social media information seeking has a positive relationship with hoarding. Further, these effects are significant when consumers attribute the scarcity responsibility to insufficient supply but not high demand. Study 2 shows that when the cause of scarcity is stated directly, perceived scarcity increases hoarding intention for Chinese consumers when the scarcity cause is due to supply but not demand, whereas U.S. consumers’ hoarding intention does not vary with the scarcity cause. The findings underscore cross-cultural differences in how legacy and social media information seeking influence consumer hoarding and highlight implications for situations in which hoarding is likely. | N/A | 2022 | | CORD-19 |
| 3241 | The Patient Perspective of Telemedicine in the Context of COVID-19 Pandemic COVID-19 Pandemic might be considered as a catalyst for transformation in healthcare experience via the use of video consultation as a method for telemedicine. The aim of our qualitative study is to understand the patient perception of video consultations in telemedicine, which has been used by a single pulmonologist in only one university hospital in Turkey since the first three months of the pandemic. Research findings are essential when it comes to a more effective and widespread future use of telemedicine, as it focuses on patient experience about a medical technology that is newly introduced. Totally 30 patients were randomly chosen and interviewed who get healthcare support via telemedicine. A semi-structured questionnaire was used to learn the experiences and opinions of the interviewees. The expressions of the patients highlight some advantages of using telemedicine such as being free from risk of contagion caused by exposure in the hospital, being able to save time and money while reaching to the physician online whenever needed, and success in technical details even though they were experiencing it for the first time. A very few of the patients are feeling discomfort to be in front of the screen. Almost all patients are applicants to suggest to other individuals the system they used, in conditions to be appropriate, and continuity after the pandemic period. Since the pandemic has propagated from one patient, the worldwide implementation of telemedicine might be catalyzed by following in the footsteps of the sporadic examples of decisiveness nourished from patient experiences. | Bull Sci Technol Soc | 2022 | | CORD-19 |
| 3242 | Probation and COVID-19: Lessons learned to improve health-related practice Probation staff perform a health-related role involving identifying health-related drivers of offending behaviour; facilitating access to support for these, including continuity of care for people leaving prison; and advising the courts on appropriate sentencing. This study analyses data from probation staff surveys and interviews with people that were under probation supervision during the pandemic to investigate the impact of the response to the pandemic on a) this health-related role, b) the lived experience of accessing health support whilst engaging with probation, and c) partnership working and pathways into healthcare for people under probation supervision. | Probat J | 2022 | | CORD-19 |
| 3243 | Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies (Adv. Sci. 11/2022) Covid‐19 Variants and Prevention Preventive strategies such as vaccines, repurposed drugs and physical‐materials science based scenarios to create vectors interacting with SARS‐CoV‐2 to tackle the spread of the virus and its various mutations have been an exceptional addition to humanity's arsenal to cope with the ongoing Covid‐19 pandemic. More details can be found in article number 2104495 by Mohan Edirisinghe and co‐workers. [Image: see text] | Adv Sci (Weinh) | 2022 | | CORD-19 |
| 3244 | It is a great course with amazing support | N/A | 2022 | | CORD-19 |
| 3245 | It's time to talk about the M word | N/A | 2022 | | CORD-19 |
| 3246 | I want to help as many people as possible | N/A | 2022 | | CORD-19 |
| 3247 | Up Front | Diabetologia | 2022 | | CORD-19 |
| 3248 | TELEMEDICINE FOR SYMPTOMS MANAGEMENT IN ORAL MEDICINE Objectives The recent coronavirus disease 2019 pandemic has caused a significant drop in visits to dental and medical practices. Following the shelter‐in‐place orders across the United States, we have implemented tele (oral) medicine for the diagnosis and management of oral medicine conditions. We aimed to (1) characterize a cohort of oral medicine patients seen via telemedicine and (2) assess the effectiveness of telemedicine visits in terms of pain control in patients affected by oral diseases. Study Design A retrospective chart review for patients seen via telemedicine was conducted between March 2020 and December 2020. Sociodemographic information, home ZIP code, referring doctor and type of insurance, and clinical diagnosis were collected and entered into an electronic database. The pain score was recorded at each visit using a 0 to 10 scale. Descriptive statistics were used to calculate median and range. Differences in oral pain were evaluated using the Wilcoxon signed-rank test. Results A total of 137 new patients were included (57% female), with a median age of 56 years (range, 3-89). If seen in person, patients would have traveled a median distance of 65 miles (range, 0.9-100). More than half of the patients (n = 82; 59.8%) were referred by physicians, with the greatest proportion coming from primary care physicians (n = 47; 34.3%) and otolaryngologists (n = 17; 12%). The most common oral conditions seen were reactive/inflammatory lesions (n = 70; 51%), orofacial pain disorders (n = 18; 13.1%), and immune-mediated conditions (n = 17; 12.4%). One third of patients (n = 51; 37%) required an oral biopsy. Imaging and laboratory studies were ordered in 9.4% and 2.1% patients, respectively. Most patients (n = 92; 67.1%) had their visit covered by private medical insurance, 9 by dental insurance (6.5%), and 31 by Medicare (22.6%%), and 5 were self-pay (3.6%). When pain was considered, there was a 3-point median pain reduction from the first video visit to the first follow-up (P < .05) and a self-reported 65% (range, 0%-100%) median improvement of oral symptoms. Conclusions Tele (oral) medicine was an effective method for the diagnosis and treatment of oral medicine conditions. Tele (oral) medicine may be used in the future for an initial screening of oral mucosal conditions and to improve access to care. | Oral Surg Oral Med Oral Pathol | 2022 | | CORD-19 |
| 3249 | COVID-19 RISK ASSESSMENT OF DENTAL SCHOOL PATIENTS FOR SAFE CLINICAL CARE STRATEGIES Objectives This quality improvement and safety project assessed the coronavirus disease 2019 (COVID-19) risk factors of the patient population at the University of Colorado School of Dental Medicine for the purpose of developing an operational strategy for modifying patient care protocols and clinic infrastructure during the pandemic. Study Design The data consist of retrospectively collected information on all patients treated at the University of Colorado School of Dental Medicine between March 1, 2019, and March 31, 2020, retrieved from the electronic dental health record. Variables of interest focused on patients treated by predoctoral students and included age group, race/ethnicity, and major comorbidities for COVID-19 risk. Patients were placed into 3 risk categories based on age and health status: Minimal (no comorbidities), high (comorbidities), and highest (>65 years and comorbidities). Descriptive statistics were calculated on the cohort. No hypothesis testing or statistical inference was employed. Results A total of 10,958 patients, with a median age of 53 (interquartile range, 34, 67) and equal sex distribution (F = 50%; M = 49.8%), treated by predoctoral students were identified. White, Hispanic, black, and mixed race accounted for 58.4%, 20.9%, 13.1%, and 2.2%, respectively. Regarding major comorbidities, 29.9% had 1, 14.8% had 2, and 9.1% had ≥3 (median = 1; interquartile range, 0, 1), with 53.5% of those ≥65 years having 3+ diseases. The most common comorbidities were cardiovascular disease (24.5%); diabetes (9.9%); immunocompromised, including HIV; and chronic corticosteroid use (9.5%), cancer (8.2%), and pulmonary disease (7.9%). The prevalence of tobacco smoking was 26.5%. Most patients were defined as high (30.9%) or highest (23%) risk, with 77.5% of those ≥75 years in the highest risk category. Stratifying by race/ethnicity, those with ≥1 comorbidities were distributed as follows: white = 62.3%, black = 56.8%, Hispanic = 40.4%, and mixed race = 64.4%. Conclusions Most patients treated by predoctoral dental students in the main clinic were classified as high or highest risk for COVID-19 infection, and this risk increased with age. Information from this quality improvement project was critical for understanding the medical complexity of the patient pool and justifying major scheduling and infrastructure changes for safe delivery of clinical care in an academic environment. | Oral Surg Oral Med Oral Pathol | 2022 | | CORD-19 |
| 3250 | The meeting point of airway enthusiasts from the past to the future: European Airway Congress | N/A | 2022 | | CORD-19 |
